74 results on '"Cordova B"'
Search Results
2. STRUTTURE IN ACCIAIO: FATICA OLIGOCICLICA
3. BCP System – Guidance Service
4. Lipid Composition of the Liver Oil of Shark Species from the Caribbean and Gulf of California Waters
5. Experience on cellular selection of CD 133+ of bone marrow aspirates and the collection of peripheral blood hematopoietic progenitors for cardiac autologous cell therapy
6. ChemInform Abstract: The Synthesis and Evaluation of Cyclic Ureas as HIV Protease Inhibitors: Modifications of the P1/P1′ Residues.
7. ChemInform Abstract: Potent Cyclic Urea HIV Protease Inhibitors with Benzofused Heterocycles as P2/P2′ Groups.
8. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2.
9. ChemInform Abstract: A Bis‐(N‐3‐(1‐hydroxy‐1‐methyl‐ethyl)‐benzyl)‐cyclic Urea as a HIV Protease Inhibitor.
10. DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein
11. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes.
12. 4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors
13. Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz
14. Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors
15. A bis-[N-3-(1-hydroxy-1-methyl-ethyl)-benzyl)-cyclic urea as a HIV protease inhibitor
16. Nonsymmetric P2/P2 Cyclic Urea HIV Protease Inhibitors. Structure−Activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues
17. Design, Synthesis, and Evaluation of Tetrahydropyrimidinones as an Example of a General Approach to Nonpeptide HIV Protease Inhibitors
18. Improved P1/P1 Substituents for Cyclic Urea Based HIV-1 Protease Inhibitors: Synthesis, Structure−Activity Relationship, and X-ray Crystal Structure Analysis
19. The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitors
20. Potent cyclic urea HIV protease inhibitors with 3-aminoindazole p2/p2' groups
21. The synthesis and evaluation of cyclic ureas as hiv protease inhibitors: modifications of the P1/P1' residues
22. Potent Cyclic Urea HIV Protease Inhibitors with Benzofused Heterocycles as P2/P2' Groups
23. Synthesis and Evaluation of Efavirenz (SustivaTM) Analogues as HIV-1 Reverse Transcriptase Inhibitors: Replacement of the Cyclopropylacetylene Side Chain
24. Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors
25. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor.
26. ChemInform Abstract: The Synthesis and Evaluation of Cyclic Ureas as HIV Protease Inhibitors: Modifications of the P1/P1′ Residues.
27. Alkaloids from Rauwolfia psychotrioides
28. Multidisciplinary Home-Based Rehabilitation Program for Individuals With Disabilities: Longitudinal Observational Study.
29. Comparative Analysis of Ventilatory Responses during Stress Tests in Patients with Chronic Pain: Implications for Therapeutic Interventions.
30. PHARMACOKINETICS AND EFFICACY OF A SINGLE TOPICAL DOSE OF EPRINOMECTIN IN GIRAFFE ( GIRAFFA SPP.).
31. CoproID predicts the source of coprolites and paleofeces using microbiome composition and host DNA content.
32. Comparative analysis of the boundary layer filtering of odor signals in the amblypygid (whip spider) species Paraphrynus laevifrons and Phrynus marginemaculatus.
33. ThiN as a Versatile Domain of Transcriptional Repressors and Catalytic Enzymes of Thiamine Biosynthesis.
34. Conserved active site cysteine residue of archaeal THI4 homolog is essential for thiamine biosynthesis in Haloferax volcanii.
35. Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease.
36. DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants.
37. Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors.
38. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
39. Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase.
40. 3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors.
41. Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors.
42. Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA).
43. Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: novel biaryl indazoles as P2/P2' substituents.
44. Synthesis and evaluation of analogs of Efavirenz (SUSTIVA) as HIV-1 reverse transcriptase inhibitors.
45. Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1' substituents.
46. Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors
47. Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.
48. Population dynamics studies of wild-type and drug-resistant mutant HIV in mixed infections.
49. Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors.
50. Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: synthesis, structure-activity relationship, and X-ray crystal structure analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.